Lakewood-Amedex is a privately held, clinical stage pharmaceutical company developing a broad portfolio of first-in-class antimicrobial and antifungal therapeutics called bisphosphocins. The rapid bactericidal action of this novel class of antimicrobials has been demonstrated against more than 70 different bacterial strains so far, including many antibiotic-resistant and biofilm forming bacteria. In the growing crisis of multi...
Lakewood-Amedex is a privately held, clinical stage pharmaceutical company developing a broad portfolio of first-in-class antimicrobial and antifungal therapeutics called bisphosphocins. The rapid bactericidal action of this novel class of antimicrobials has been demonstrated against more than 70 different bacterial strains so far, including many antibiotic-resistant and biofilm forming bacteria. In the growing crisis of multidrug-resistant infections, Lakewood’s clinical development pipeline is focused on addressing the most life-threatening disease indications.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.